Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results
|
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/02/2023 |
8-K
| Quarterly results |
08/07/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/07/2023 |
8-K
| Quarterly results
Docs:
|
"Assets Current assets Cash and cash equivalents $ 63,212 $ 21,929 Accounts receivable 46,553 54,826 Net investment in leases 13,219 16,130 Inventories 20,315 23,124 Income taxes receivable 1,779 — Prepaid expenses and other current assets 4,480 3,754 Total current assets 149,558 119,763 Non-current assets Property and equipment, net 5,771 6,077 Right of use operating lease assets 20,041 21,322 Intangible assets, net 48,559 50,375 Goodwill 31,063 31,063 Accounts receivable, non-current 15,430 23,061 Other non-current assets 3,306 3,335 Total non-current assets 124,170 135,233 Total assets $ 273,728 $ 254,996 Liabilities and Stockholders' Equity Current liabilities Accounts payable $ 9,296 $ 9,984 Note payable 2,968 2,968 Earn-out, current 9,280 13,050 Accrued payroll and related taxes 13,80..." |
|
08/07/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/28/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
07/18/2023 |
8-K
| Quarterly results |
05/24/2023 |
SD
| Form SD - Specialized disclosure report: |
05/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
05/09/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
05/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
05/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
05/08/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
05/08/2023 |
8-K
| Quarterly results |
03/27/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
03/27/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
03/27/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
03/14/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
02/28/2023 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive Data
Docs:
|
"Underwriting Agreement, between the Company and William Blair & Company, L.L.C., as the underwriter",
"Opinion of Faegre Drinker Biddle & Reath LLP",
"Tactile Systems Technology, Inc. Announces Proposed Public Offering of Common Stock MINNEAPOLIS, Minn.——Feb. 23, 2023— Tactile Systems Technology, Inc. , a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, announced today that it intends to offer and sell shares of its common stock in an underwritten public offering. Tactile Medical intends to grant the underwriter a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the offering at the public offering price, less the underwriting discounts and commissions. All of the shares of common stock to be sold in the proposed offering will be sold by Tactile Medical. The offering is subject to market and other conditions, ...",
"Tactile Systems Technology, Inc. Announces Pricing of $32.5 Million Public Offering of Common Stock MINNEAPOLIS, Minn.—— Feb. 23, 2023— Tactile Systems Technology, Inc. , a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today announced the pricing of an underwritten public offering of 2,500,000 shares of its common stock at a price to the public of $13.00 per share. The gross proceeds to Tactile Medical from the offering, before deducting the underwriting discounts and commissions and estimated offering expenses, are expected to be $32.5 million. Additionally, Tactile Medical has granted the underwriter a 30-day option to purchase up to an additional 375,000 shares of its common stock at the public o..." |
|
02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 6% stake in Tactile Systems Technology Inc. |
02/06/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
01/26/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
01/23/2023 |
SC 13G/A
| MILLENNIUM MANAGEMENT LLC reports a 3.8% stake in TACTILE SYSTEMS TECHNOLOGY, INC. |
01/23/2023 |
SC 13G/A
| BlackRock Inc. reports a 11.1% stake in TACTILE SYSTEMS TECHNOLOGY INC |
01/18/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
01/05/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
12/23/2022 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits ... |
11/29/2022 |
8-K
| Quarterly results |
11/07/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
11/07/2022 |
8-K
| Quarterly results
Docs:
|
"Third Quarter Revenue Increased 24% Year-Over-Year; First Nine Months Revenue Increased 18% Year-Over-Year MINNEAPOLIS, MN, November 7, 2022 – Tactile Systems Technology, Inc. , a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today reported financial results for the third quarter and nine months ended September 30, 2022. Third Quarter 2022 Summary: ● Total revenue increased 24% year-over-year to $65.3 million, compared to $52.5 million in third quarter 2021. ● Total revenue in third quarter 2022 included $11.0 million of revenue from sales of airway clearance products, which includes the AffloVest product line acquired on September 8, 2021, compared to $0.9 million of revenue in third qu..." |
|
10/07/2022 |
SC 13G/A
| BlackRock Inc. reports a 10.4% stake in TACTILE SYSTEMS TECHNOLOGY INC |
08/01/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
08/01/2022 |
8-K
| Quarterly results
Docs:
|
"Second Quarter Revenue Increased 17% Year-Over-Year; First Half Revenue Increased 15% Year-Over-Year MINNEAPOLIS, MN, August 1, 2022 – Tactile Systems Technology, Inc. , a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today reported financial results for the second quarter and six months ended June 30, 2022. Second Quarter 2022 Summary: ● Total revenue increased 17% year-over-year to $59.6 million, compared to $51.1 million in second quarter 2021. ● Total revenue in second quarter 2022 included $8.0 million of revenue from sales of airway clearance products, which includes the AffloVest product line acquired on September 8, 2021. ● Operating loss of $4.1 million, compared to $0.1 m..." |
|
|
|
|